Special notice: Important policy changes
Mar. 2025Important Notices
Effective May 1, 2025, the following policies will be retired and replaced with prior authorization policies. For more information, please visit upmchp.us/policiesandprocedures.
- Brachytherapy-MP.220 is being retired and will be replaced by Brachytherapy-MP.PA.139.
- Implantable Loop Recorder (Subcutaneous) Cardiac Rhythm Monitor – MP.165 is being retired and will be replaced by Implantable Loop Recorder (Subcutaneous) Cardiac Rhythm Monitor – MP.PA.140.
- Radiation Therapy, External Beam (EBRT) and Intensity-Modulated (IMRT) – MP.034 is being retired and will be replaced with Radiation Therapy, External Beam (EBRT) and Intensity-Modulated (IMRT) – MP.PA.142.
- Radiation Therapy - SRS and SBRT – MP.060 is being retired and will be replaced with Radiation Therapy - SRS and SBRT – MP.PA.143.
- Sleep Medicine – Sleep Study – MP.157 is being retired and will be replaced with Sleep Medicine – Sleep Study – MP.PA.144.
Again, prior authorization will be required for all of the new policies beginning May 1.
If you have any questions or concerns about these policy changes, please contact your physician account executive or call Provider Services at 1-866-918-1595.
Thank you for the excellent care and support you provide to our members.
Recent Announcements
CME Webinar: The State of Telehealth in 2026
Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.Dec. 2025Education/Webinars
Formulary updates effective Jan. 1, 2026
Review upcoming policy and operational updatesDec. 2025Pharmacy Updates
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates